Given the availability of pharmacological BAF inhibitors and their reported CD8+-intrinsic and -extrinsic tumor suppression, elucidating molecular mechanisms of how BAF complexes coordinately regulate CD8+ T cell differentiation will likely gain more attraction in the future. This evidence concerns the gene CD8A and neoplasm.